Back
Dave, Inc. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Buy
56
DAVE
Dave, Inc.
Last Price:
$215.15
Seasonality Move:
68.23%
Buy
59
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$19.90
Seasonality Move:
115.37%
Buy
56
Dave, Inc. (DAVE)
is a Buy
Is Dave, Inc. a Buy, Sell or Hold?
-
The current Dave, Inc. [DAVE] share price is $215.25. The Score for DAVE is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
DAVE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $19.81. The Score for RGC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVE Stock Price Chart
What is Dave, Inc.'s stock price today?
-
The Dave, Inc. share price today is $215.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVE is experiencing slight buying pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $19.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.81 | Sell |
| Relative Strength Index (14 RSI): | 54.85 | Buy |
| Chaikin Money Flow: | 3344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (192.95 - 209.99) | Buy |
| Bollinger Bands (100): | (194.74 - 230.6) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.53 | Buy |
| Relative Strength Index (14 RSI): | 73.67 | Buy |
| Chaikin Money Flow: | 226759 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.01 - 17.15) | Buy |
| Bollinger Bands (100): | (12.7 - 16.82) | Buy |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 201.22 | Buy |
| 20-day SMA: | 203.71 | Buy |
| 50-day SMA: | 215.53 | Sell |
| 200-day SMA: | 186.35 | Buy |
| 8-day EMA: | 204.05 | Buy |
| 20-day EMA: | 204.94 | Buy |
| 50-day EMA: | 210.07 | Buy |
| 200-day EMA: | 184.46 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.41 | Buy |
| 20-day SMA: | 15.03 | Buy |
| 50-day SMA: | 15.12 | Buy |
| 200-day SMA: | 12.83 | Buy |
| 8-day EMA: | 9.93 | Buy |
| 20-day EMA: | 4.83 | Buy |
| 50-day EMA: | 2.1 | Buy |
| 200-day EMA: | 0.55 | Buy |
Dave, Inc. Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.18 per share, and an increase next year of $0.09 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Dave, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||